Back to search

Chronic administration of the selective dopamine uptake inhibitor GBR 12909, but not cocaine, produces marked decreases in dopamine transporter density

Data up to Jan 2025

Published1997
Citations33
References40

Total Citations Per Year

Abstract

References (40)

Cloning and Expression of a Cocaine-Sensitive Rat Dopamine Transporter

1991 • 587 citations

Cloning and Expression of a Cocaine-Sensitive Dopamine Transporter Complementary DNA

1991 • 584 citations

The dopamine uptake inhibitor GBR 12909: selectivity and molecular mechanism of action

1989 • 343 citations

Behavioral properties of GBR 12909, GBR 13069 and GBR 13098: Specific inhibitors of dopamine uptake

1984 • 233 citations

Cocaine binding at σ receptors

1988 • 208 citations

Cocaine disposition in the brain after continuous or intermittent treatment and locomotor stimulation in mice.

1987 • 193 citations

A review of the effects of dopaminergic agents on humans, animals, and drug-seeking behavior, and its implications for medication development

1995 • 164 citations

Differences in Dopamine Clearance and Diffusion in Rat Striatum and Nucleus Accumbens Following Systemic Cocaine Administration

1992 • 152 citations

ChemInform Abstract: ARYL 1,4‐DIALK(EN)YLPIPERAZINES AS SELECTIVE AND VERY POTENT INHIBITORS OF DOPAMINE UPTAKE

1981 • 150 citations

Cocaine use increases [3HWIN 35428 binding sites in human striatum

1993 • 129 citations

Comparison of the effects of cocaine and other inhibitors of dopamine uptake in rat striatum, nucleus accumbens, olfactory tubercle, and medial prefrontal cortex

1990 • 128 citations

High-affinity [3H]GBR 12783 binding to a specific site associated with the neuronal dopamine uptake complex in the central nervous system

1986 • 110 citations

Intermittent and Continuous cocaine Administration: Residual Behavioral states during withdrawal

1992 • 108 citations

GBR12909 attenuates cocaine-induced activation of mesolimbic dopamine neurons in the rat.

1994 • 103 citations

Neurotransmitter Transporters: Molecular Biology, Function, and Regulation

1995 • 101 citations

Reduction in dopamine transporter mRNA after cessation of repeated cocaine administration

1994 • 94 citations

Dopamine uptake sites in the striatum are distributed differentially in striosome and matrix compartments.

1989 • 88 citations

Lack of increase in dopamine transporter binding or function in rat brain tissue after treatment with blockers of neuronal uptake of dopamine

1991 • 83 citations

Inhibition of dopamine uptake by cocaine and nicotine: tolerance to chronic treatments

1992 • 82 citations

Cocaine and GBR12909 produce equivalent motoric responses at different occupancy of the dopamine transporter

1992 • 81 citations

Differential reinforcing effects of cocaine and GBR-12909: biochemical evidence for divergent neuroadaptive changes in the mesolimbic dopaminergic system.

1996 • 79 citations

Dopamine transporters in the nucleus accumbens and the striatum have different apparent molecular weights

1991 • 79 citations

Evidence for mutually exclusive binding of cocaine, BTCP, GBR 12935, and dopamine to the dopamine transporter

1992 • 76 citations

[3H]cocaine binding and inhibition of [3H]dopamine uptake is similar in both the rat striatum and nucleus accumbens

1989 • 76 citations

Quantitation of Rat Dopamine Transporter mRNA: Effects of Cocaine Treatment and Withdrawal

1992 • 63 citations

Differential relationships among dopamine transporter affinities and stimulant potencies of various uptake inhibitors

1994 • 59 citations

Unaltered [3H]GBR-12935 binding after chronic treatment with dopamine active drugs

1990 • 57 citations

Dopamine transporter: deglycosylation with exo- and endoglycosidases

1991 • 48 citations

Expression of a single dopamine transporter cDNA can confer two cocaine binding sites

1992 • 44 citations

Evidence that pure uptake inhibitors including cocaine interact slowly with the dopamine neuronal carrier

1994 • 42 citations

Cocaine and GBR 12783 recognize nonidentical, overlapping binding domains on the dopamine neuronal carrier

1994 • 39 citations

Neuropeptide-dopamine interactions. V. Cyclo(His-Pro) regulation of striatal dopamine transporter complex

1990 • 35 citations

Isothiocyanate derivatives of cocaine: irreversible inhibition of ligand binding at the dopamine transporter.

1991 • 34 citations

GBR 12909 and 12935 block dopamine uptake into brain synaptic vesicles as well as nerve endings

1994 • 30 citations

Interaction of [3H]GBR 12935 and GBR 12909 with the dopamine uptake complex in nucleus accumbens

1990 • 29 citations

Dopaminergic modulation of serotonin metabolism in rat striatum: A study with dopamine uptake inhibitor GBR-12909

1995 • 20 citations

Characterization of binding of [3H]GBR 12935 (1-[2-(diphenylmethoxy)ethyl]-4-(3-phenylpropyl)-piperazine) to membranes and to solubilized membrane extracts from terminal field regions of mesolimbic, mesocortical and nigrostriatal dopamine pathways

1990 • 16 citations

The cocaine analog WIN 35,428 binds to two sites in fresh rat caudate-putamen: Significance of assay procedures

1993 • 16 citations

Increased μ-opioid efficacy for inhibition of adenylyl cyclase induced by chronic treatment with naltrexone or cocaine

1994 • 4 citations

Invariance of the density of dopamine uptake sites and dopamine metabolism in the rat brain after a chronic treatment with the dopamine uptake inhibitor GBR 12783

1994 • 3 citations

Cited By (0)

Loading...
Chronic administration of the selective dopamine uptake inhibitor GBR 12909, but not… (1997) – Naunyn-Schmiedeberg s Archives of Pharmacology | Metascience Observatory Explorer